Stepwise optimisation of balloon pulmonary angioplasty in a patient with severe non-operable chronic thromboembolic pulmonary hypertension Araszkiewicz A, Jankiewicz S, Mularek-Kubzdela T, Lesiak M February 20, 2018 | 10.4244/EIJ-D-17-00382
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Münzel T, Capranzano P, Di Mario C, Naber C, Araszkiewicz A, Colombo A, Caramanno G, Sabaté M, Tamburino C, Nef H, Gori T October 11, 2017 | 10.4244/EIJ-D-16-00568
Coronary interventions Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S April 20, 2017 | 10.4244/EIJ-D-16-00974
Coronary interventions Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry Gori T, Wiebe J, Capodanno D, Latib A, Lesiak M, Pyxaras S, Mehilli J, Caramanno G, Di Mario C, Brugaletta S, Weber J, Capranzano P, Sabaté M, Mattesini A, Geraci S, Naber C, Araszkiewicz A, Colombo A, Tamburino C, Nef H, Münzel T August 5, 2016 | 10.4244/EIJY15M09_10
Coronary interventions Percutaneous coronary intervention for chronic total occlusion of the coronary artery with the implantation of bioresorbable everolimus-eluting scaffolds. Poznan CTO-Absorb Pilot Registry Lesiak M, Łanocha M, Araszkiewicz A, Siniawski A, Grygier M, Pyda M, Olasińska-Wiśniewska A, Iwanczyk S, Skorupski W, Mitkowski P, Lesiak M, Grajek S June 10, 2016 | 10.4244/EIJV12I2A27
Coronary interventions Lessons from the GHOST-EU registry Latib A, Capodanno D, Lesiak M, Tamburino C, Colombo A May 19, 2015 | 10.4244/EIJV11SVA41
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective Tamburino C, Latib A, van Geuns R, Sabaté M, Mehilli J, Gori T, Achenbach S, Alvarez M, Nef H, Lesiak M, Di Mario C, Colombo A, Naber C, Caramanno G, Capranzano P, Brugaletta S, Geraci S, Araszkiewicz A, Mattesini A, Pyxaras S, Rzeszutko L, Depukat R, Diletti R, Boone E, Capodanno D, Dudek D May 19, 2015 | 10.4244/EIJY15M01_05
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C February 20, 2015 | 10.4244/EIJY14M07_11
The Great Debate: “Primary PCI for STEMI: an emergency!” Lesiak M, Strange J August 19, 2014 | 10.4244/EIJV10STA6
Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies Grundeken M.J, Asgedom S, Damman P, Lesiak M, Norell M, Garcia E, Bethencourt A, Woudstra P, Koch K, Vis M, Henriques J, Onuma Y, Foley DP, Bartorelli A, Stella P, Thijssen J, de Winter R, Wykrzykowska J June 28, 2013 | 10.4244/EIJV9I2A34
Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry Magro M, Girasis C, Bartorelli A, Tarantini G, Russo F, Trabattoni D, D’Amico G, Galli M, Juame A, de Sousa Almeida M, Simsek C, Foley DP, Sonck J, Lesiak M, Kayaert P, Serruys P, van Geuns R March 22, 2013 | 10.4244/EIJV8I11A194
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population Gil R, Vassilev D, Michalek A, Kern A, Formuszewicz R, Dobrzycki S, Wójcik J, Lesiak M, Kardaszewicz P, Lekston A July 27, 2012 | 10.4244/EIJV8I3A50
A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry Agostoni P, Foley DP, Lesiak M, Belkacemi A, Dens J, Kumsars I, Scott B, Oemrawsingh P, Dubois C, Garcia E, Lefèvre T, Stella P March 21, 2012 | 10.4244/EIJV7I11A204
Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial Costa R, Abizaid A, Abizaid An, Del Blanco B, Berland J, Petrov I, Brenot P, van Geuns R, Royer T, Rubino P, Lesiak M, Fajadet J March 21, 2012 | 10.4244/EIJV7I11A205
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019